We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+3.89%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$488M
AUM Growth
-$16.7M
Cap. Flow
-$12.4M
Cap. Flow %
-2.53%
Top 10 Hldgs %
24.18%
Holding
436
New
75
Increased
50
Reduced
159
Closed
70

Top Buys

Rank Stock Value
1
APA icon
APA Corp
APA
+$9.18M
2
TGT icon
Target
TGT
+$8.61M
3
DVN icon
Devon Energy
DVN
+$8.4M
4
COR icon
Cencora
COR
+$8.27M
5
BIIB icon
Biogen
BIIB
+$8.23M

Top Sells

Rank Stock Value
1
SPOT icon
Spotify
SPOT
+$11.8M
2
NFLX icon
Netflix
NFLX
+$10.4M
3
SHOP icon
Shopify
SHOP
+$10.1M
4
CEG icon
Constellation Energy
CEG
+$9.01M
5
COST icon
Costco
COST
+$8.88M

Sector Composition

Rank Sector Weight
1 Technology 20.56%
2 Financials 18.66%
3 Industrials 11.39%
4 Healthcare 11.19%
5 Energy 7.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMBJ
176
Embraer S.A. ADS
EMBJ
$13.1B
$286K 0.06%
4,825
-357
-7% -$24.4K
NMIH icon
177
NMI Holdings
NMIH
$3.32B
$286K 0.06%
7,616
GVA icon
178
Granite Construction
GVA
$5.51B
$285K 0.06%
2,378
-438
-16% -$54.7K
TEX icon
179
Terex
TEX
$7.58B
$284K 0.06%
+4,800
New +$297K
SAN icon
180
Banco Santander
SAN
$210B
$283K 0.06%
+25,085
New +$299K
DK icon
181
Delek US
DK
$3.72B
$279K 0.06%
6,188
NGVT icon
182
Ingevity
NGVT
$2.65B
$278K 0.06%
+3,908
New +$267K
DNLI icon
183
Denali Therapeutics
DNLI
$4B
$277K 0.06%
+14,451
New +$288K
IDYA icon
184
IDEAYA Biosciences
IDYA
$3.54B
$273K 0.06%
8,183
TRMK icon
185
Trustmark
TRMK
$2.75B
$272K 0.06%
6,463
FBNC icon
186
First Bancorp
FBNC
$2.68B
$265K 0.05%
+4,698
New +$268K
MTRN icon
187
Materion
MTRN
$5.83B
$264K 0.05%
1,827
GLD icon
188
SPDR Gold Trust
GLD
$143B
$262K 0.05%
609
-35
-5% -$15.7K
ING icon
189
ING
ING
$101B
$259K 0.05%
9,960
-325
-3% -$9.14K
CENT icon
190
Central Garden & Pet Co
CENT
$2.75B
$259K 0.05%
+7,050
New +$252K
AER icon
191
AerCap
AER
$23.5B
$259K 0.05%
1,889
-67
-3% -$9.58K
BABA icon
192
Alibaba
BABA
$317B
$259K 0.05%
2,063
-114
-5% -$17.1K
UNFI icon
193
United Natural Foods
UNFI
$2.8B
$257K 0.05%
5,708
DX
194
Dynex Capital
DX
$3.17B
$246K 0.05%
+19,250
New +$265K
CUBI icon
195
Customers Bancorp
CUBI
$2.78B
$244K 0.05%
3,514
SPNT icon
196
SiriusPoint
SPNT
$2.63B
$242K 0.05%
11,256
PRDO icon
197
Perdoceo Education
PRDO
$1.97B
$241K 0.05%
6,479
BEAM icon
198
Beam Therapeutics
BEAM
$2.82B
$240K 0.05%
10,061
CBRE icon
199
CBRE Group
CBRE
$41.7B
$238K 0.05%
1,754
-4
-0.2% -$608
HLIO icon
200
Helios Technologies
HLIO
$2.69B
$236K 0.05%
+3,644
New +$244K

Similar funds

Contravisory Investment Management's Q1 2026 Portfolio in Review

As of Q1 2026, Contravisory Investment Management held 436 positions worth $488M, down 3.3% from $505M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Contravisory Investment Management's Q1 2026 filing shows 75 new, 50 increased, 159 reduced and 70 closed positions. Its largest new stake was Target: 76,407 shares worth $9.26M. The largest sale was Spotify, an estimated $11.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.

  • Contravisory Investment Management's largest Q1 2026 buy was Target: 76,407 shares worth $9.26M.
  • Contravisory Investment Management added most to APA Corp in Q1 2026, an estimated $9.18M increase.
  • Contravisory Investment Management's biggest Q1 2026 reduction was CMS Energy, cutting an estimated $8.62M.
  • Contravisory Investment Management fully exited Spotify in Q1 2026, selling an estimated $11.8M.
  • Contravisory Investment Management's ten largest holdings make up 24% of its $488M portfolio in Q1 2026.
  • Contravisory Investment Management opened 75 new positions and closed 70 in Q1 2026.
  • Contravisory Investment Management's portfolio value fell 3.3% quarter-over-quarter to $488M.

Based on Contravisory Investment Management's 13F filing for Q1 2026, filed 20 Apr 2026.